Evidence map›Paper›PMID 22084840›Full record

Trial reportCulture, health & sexuality2012

Variations in microbicide gel acceptability among young women in the USA and Puerto Rico.

Rebecca Giguere, Alex Carballo-Diéguez, Ana Ventuneac, Marina Mabragaña, Curtis Dolezal, Beatrice A Chen, Jessica A Kahn, Gregory D Zimet, Ian McGowan

Open access · greenAbstract readClinical Trial, Phase IMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Culture, health & sexuality, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
8.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. On-demand microbicide products: design matters.Drug delivery and translational research · 2017
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Young women's experience with using videoconferencing for the assessment of sexual behavior and microbicide use.Telemedicine journal and e-health : the official journal of the American Telemedicine Association · 2013
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 1 country.

Rebecca GiguereHIV Center for Clinical and Behavioral Studies, New York State Psychiatric Institute and Columbia University, New York, NY, USA. giguere@nyspi.columbia.edu
Alex Carballo-Diéguez
Ana Ventuneac
Marina Mabragaña
Curtis Dolezal
Beatrice A Chen
Jessica A Kahn
Gregory D Zimet
Ian McGowan
Columbia University · USNew York Psychoanalytic Society and Institute · USCity University of New York · USIndiana University School of MedicineMagee-Womens Research Institute · USUniversity of Cincinnati · USUniversity of Pittsburgh · US

Funding

Adol. Medicine Trials Network for HIV/AIDS InterventionsU01HD040474 · NICHD · WESTAT, INC. · PI HARRIS, DONALD ROBERT · 2001 to 2016
$114.4M
Microbicide Trials NetworkU01AI068633 · NIAID · MAGEE-WOMEN'S RES INST AND FOUNDATION · PI HILLIER, SHARON L. · 2006 to 2010
$77.0M
LEADERSHIP GROUP FOR ADOLESCENT MEDICINE TRIALS NETWORKU01HD040533 · NICHD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WILSON, CRAIG M · 2001 to 2016
$76.4M
Statistical and Data Management Center (SDMC): Microbicide Trials NetworkUM1AI068615 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BROWN, ELIZABETH RENATA · 2011 to 2021
$66.5M
The Statistics, Data Science, and Data Management (SDM) CoreP30MH043520 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI MILTON L WAINBERG · 2003 to 2026
$48.2M
Leadership for HIV/AIDS Clinical Trials Networks; Microbicide Trials NetworkU01AI068615 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI RICHARDSON, BARBRA A · 2006 to 2010
$20.4M
NIAID NIH HHS U01 AI068615NIAID NIH HHS U01AI068615NIAID NIH HHS U01 AI068633NIAID NIH HHS U01AI068633NIAID NIH HHS UM1 AI068615NICHD NIH HHS U01 HD040474NICHD NIH HHS U01 HD040533NICHD NIH HHS U01HD040533NIMH NIH HHS P30 MH043520NIMH NIH HHS P30-MH43520
6 · The paper itself

Abstract

In a multi-site study of vaginal microbicide acceptability conducted with sexually active young women, quantitative assessments revealed significant differences in acceptability by site. Participants in Puerto Rico rated the gel more favourably than mainland US participants in terms of liking the gel and likelihood of future use. To explain these differences, we examined responses to qualitative behavioural assessments. Young women in mainland USA associated gel leakage with uncomfortable sensations experienced during menstruation, while young women in Puerto Rico had positive associations of gel use with douching. These negative or positive associations affected assessments of the gel's physical qualities. In addition, young women's perceptions of primary partners' support for microbicide use influenced sexual satisfaction with the gel and, ultimately, product acceptability. Finally, geographic HIV-risk context contributed to heightened HIV-risk perception, which influenced likelihood of future microbicide use, even for women in stated monogamous relationships. Future microbicide acceptability studies should take into account potential differences in acceptability by site such as HIV-risk perception based on local HIV prevalence, popularity of vaginal hygiene products in a specific area and male attitudes in different cultures concerning women's use of HIV protection strategies.

Indexed as

Anti-Infective Agents, LocalCultural CharacteristicsFemaleHIV InfectionsHumansInterviews as TopicPatient Acceptance of Health CarePuerto RicoSexually Transmitted DiseasesUnited StatesVaginal Creams, Foams, and JelliesYoung AdultAnti-Infective Agents, LocalVaginal Creams, Foams, and Jellies

Identifiers

PMID22084840
PMCPMC3265079
OpenAlexW1988895401

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.